Pages

Wednesday, December 8, 2021

Fw: Ref.: (LML) In memoriam Prof. Dr. Luiz Ricardo Goulart Filho

 
Leprosy Mailing List – December 8,  2021

 

Ref.:  (LML) In memoriam Prof. Dr. Luiz Ricardo Goulart Filho

 

From:  Pieter Schreuder, Maastricht, the Netherlands

 

Dear colleagues,


A week ago, we received from Joel Almeida the 'In memoriam Prof. Dr. Luiz Ricardo Goulart Filho' from the Brasilian Hansenology Society:

Homenagem da Sociedade Brasileira de Hansenologia ao Prof. Dr. Luiz Ricordo Goulart Filho - SBH - Sociedade Brasileira de Hansenologia

Grande nome da ciência brasileira, Prof. Dr. Luiz Ricardo Goulart Filho, nasceu em 25 de maio de 1962 em Uberlândia/MG e faleceu em 24 de outubro de 2021 na mesma cidade, em decorrência de complicações da COVID-19.

www.sbhansenologia.org.br


http://www.sbhansenologia.org.br/noticia/homenagem-da-sociedade-brasileira-de-hansenologia-ao-prof.-dr.-luiz-ricardo-goulart

 

The translation is mine, with help from Google. My apologies for any mistake made.

 

Pieter AM Schreuder

Editor LML

 

Homenagem da Sociedade Brasileira de Hansenologia ao Prof. Dr. Luiz Ricordo Goulart Filho - SBH - Sociedade Brasileira de Hansenologia

 

An Eminent name in Brazilian science, Prof. Dr.  Luiz Ricardo Goulart Filho born on May 25, 1962 in Uberlândia/MG/Brazil died October 24, 2021 in the same city, as a result of complications from COVID-19.

 

Graduated in Biological Sciences from the Faculty of Education of Machado/MG, and in Agronomy from the Federal University of Lavras/MG (1984), Master in Genetics (1987) and Doctor in Molecular Genetics from Purdue University/Indiana/USA (1990). He had a Post-Doctorate in Molecular Pathology Molecular from Virginia Commonwealth University/USA (1999) and Post-Doctorate in Medical Microbiology and Immunology from the University of California-Davis/USA (2010), where he was also a visiting professor (2010-2012).

 

He served as Full Professor at the Federal University of Uberlândia (since 1992) and Adjunct Professor at the Department of Medical Microbiology and Immunology at the University of California-Davis/USA (since 2013). He was coordinator of the National Institute of Science and Technology in Theranostics (a combination of diagnosis and therapeutics; it provides a transition from conventional medicine to personalized medicine) and Nanobiotechnology. He coordinated the Laboratory of Nanobiotechnology, associated with SisNANO (National System of Laboratories in Nanotechnology) and served as a member of the Advisory Committee on Nanotechnology and New Materials, and as a member of the Multidisciplinary Advisory Committees and the Presidency of CNPq (National Council of Scientific and Technological Development -CNPq-, an agency of the Ministry of Science, Technology, Innovations and Communications), Biological Sciences and Biotechnology from FAPEMIG, and of the Advisory Committee of CT-INFRA from FINEP .

 

He participated in Symposiums and Congresses of the Brazilian Society of Hansenology (SBH); the 1st International Symposium on Molecular and Immunological Diagnosis of Leprosy; the 1st Meeting on Leprosy Vaccines in 2009; and the 1st Symposium on Mycobacteria and Drug Resistance in 2011, held at UFU/MG.

 

Talented and visionary, Luiz Ricardo had a great desire for new scientific knowledge. He conducted numerous researches in various areas such as Biotechnology applied to agriculture, genomes, prostate cancer and breast cancer, dengue, coronary heart disease, nanotechnology, biological sensors in human and animal infectious diseases.

 

 

His great passion was to solve challenging problems, such as neglected diseases, especially leprosy, which affect the low-income population with poor access to health. He worked at the National Reference Center for Sanitary Dermatology and Leprosy (CREDESH), Hospital de Clínicas, Federal University of Uberlândia/MG.

 

His interest in leprosy arose more than 20 years ago, under the influence of his sister Prof. Dr. Isabela Maria Bernardes Goulart, medical specialist in Hansenology. They worked together - clinical and basic research, translational studies on the mechanisms of action of the disease, seeking to translate these results into changes in clinical practice and improvements in public policies related to leprosy.

 

Among the topics of his leprosy research were: the study of genetic components associated with susceptibility and resistance to leprosy, including the first work on the Vitamin D receptor; development of new biological markers to improve the prognosis of leprosy patients and monitor reactional patients, cases of relapse and the treatment effectiveness. Due to his great experience with molecular techniques, he exposed the route of infection and transmission between symptomatic and asymptomatic patients and contacts, detecting M. leprae DNA in oral and nasal mucosa, as well as in peripheral blood. Collaborated in the application of these molecular and immunological methods for early assessment of neural damage in patients and contacts associated with electroneuromyography. He developed new biotechnological and immunological platforms, as well as perfected the existing molecular and serological techniques for the detection of M. leprae, enabling the early diagnosis of leprosy.

 

His ability to innovate and develop projects in the area of leprosy resulted in more than 30 articles published in journals, 1 book chapter, 2 texts in newspapers, 92 works published in conference proceedings, 2 patent applications and guidance of many bachelor, master and doctorate students.

 

His big dream was to develop an easy, fast, low-cost and accessible diagnostic technique that could be used in the field without the need for a specialized professional, thus revolutionizing the way of diagnosing not only leprosy, but also other infectious diseases.

 

Luiz Ricardo engaged till his last days in research, creating and constructing a method of analysis and detection by electrochemical and photonic biosensors (the same technique he used to successfully develop the first reagent-free sensor for COVID-19 applied on a world scale). This technique is able to detect the presence of M. leprae in dermal scrapings and also monitor antibodies in blood and saliva through a microchip coupled to a small analysis equipment, where results can be observed and interpreted by a cell phone application, with quick results in less than 2 minutes.

 

As a great leader who trained highly qualified professionals, Luiz Ricardo leaves a prepared multidisciplinary team that, together with Prof. Isabela Goulart, will continue their research in favour of people affected by leprosy and, in the name, respect and admiration for everything that the illustrious and unforgettable Professor Doctor Luiz Ricardo Goulart Filho has built so far.

 

Our eternal gratitude to this enlightened human being, who leaves an eternal longing in the hearts of his family, friends and society.


 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/0fb344b0-ff76-4aa7-9cc2-1b1451bf3c5dn%40googlegroups.com.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.